0000899243-17-012052.txt : 20170505
0000899243-17-012052.hdr.sgml : 20170505
20170505213413
ACCESSION NUMBER: 0000899243-17-012052
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170427
FILED AS OF DATE: 20170505
DATE AS OF CHANGE: 20170505
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Savara Inc
CENTRAL INDEX KEY: 0001160308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841318182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 150
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 8585520866
MAIL ADDRESS:
STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 150
CITY: AUSTIN
STATE: TX
ZIP: 78746
FORMER COMPANY:
FORMER CONFORMED NAME: Mast Therapeutics, Inc.
DATE OF NAME CHANGE: 20130312
FORMER COMPANY:
FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030613
FORMER COMPANY:
FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lowrance David L
CENTRAL INDEX KEY: 0001408498
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32157
FILM NUMBER: 17820086
MAIL ADDRESS:
STREET 1: 422 WILLIAM WALLACE DRIVE
CITY: FRANKLIN
STATE: TN
ZIP: 37064
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2017-04-27
0
0001160308
Savara Inc
SVRA
0001408498
Lowrance David L
900 S. CAPITAL OF TEXAS HIGHWAY,
SUITE 150
AUSTIN
TX
78746
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
1.51
2026-10-25
Common Stock
127578
D
The shares subject to the option vest and become exercisable in sixteen equal quarterly installments beginning on February 1, 2017.
/s/ David L. Lowrance
2017-05-05